Chase AIPricingFAQs
Display currency
Loading news…

SynOx Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Dublin, Ireland Founded 2020 1-10 employees For Profit

SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
8
Patents
0
4 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
30
Patents granted
0
Trademarks
4
IT spend
$52.5K

Company Info

Founded
2020
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
News articles
44
HQ
Dublin, Ireland
Region
European Union (EU), Europe, Middle East, and Africa (EMEA)

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
-0.4
Trend (30d)
-1.1
Trend (90d)
-2.5
Last leadership hire
Oct 21, 2025

Key People at SynOx Therapeutics

Chief Executive Officer
Chief Medical Officer
8
professional contacts at SynOx Therapeutics
Contact execs at SynOx Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to SynOx Therapeutics

Loading news…

FAQs about SynOx Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
SynOx Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments